TEVA
Price
$16.54
Change
+$0.21 (+1.29%)
Updated
Jul 25 closing price
Capitalization
15.06B
3 days until earnings call
VTRS
Price
$9.41
Change
+$0.06 (+0.64%)
Updated
Jul 25 closing price
Capitalization
14.18B
11 days until earnings call
Interact to see
Advertisement

TEVA vs VTRS

Header iconTEVA vs VTRS Comparison
Open Charts TEVA vs VTRSBanner chart's image
Teva Pharmaceutical Industries
Price$16.54
Change+$0.21 (+1.29%)
Volume$9.21M
Capitalization15.06B
Viatris
Price$9.41
Change+$0.06 (+0.64%)
Volume$5.03M
Capitalization14.18B
TEVA vs VTRS Comparison Chart in %
Loading...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TEVA vs. VTRS commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEVA is a StrongBuy and VTRS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (TEVA: $16.54 vs. VTRS: $9.41)
Brand notoriety: TEVA: Notable vs. VTRS: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TEVA: 87% vs. VTRS: 40%
Market capitalization -- TEVA: $15.06B vs. VTRS: $14.18B
TEVA [@Pharmaceuticals: Other] is valued at $15.06B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TEVA’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • TEVA’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than TEVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TEVA’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • TEVA’s TA Score: 3 bullish, 5 bearish.
  • VTRS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than TEVA.

Price Growth

TEVA (@Pharmaceuticals: Other) experienced а +2.99% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +5.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

TEVA is expected to report earnings on Jul 30, 2025.

VTRS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than VTRS($14.2B). VTRS has higher P/E ratio than TEVA: VTRS (238.80) vs TEVA (22.62). VTRS YTD gains are higher at: -22.370 vs. TEVA (-24.955). VTRS has higher annual earnings (EBITDA): 3.52B vs. TEVA (1.56B). TEVA has more cash in the bank: 3.23B vs. VTRS (1.18B). VTRS has less debt than TEVA: VTRS (18.4B) vs TEVA (20.2B). TEVA (15.8B) and VTRS (15.4B) have equivalent revenues.
TEVAVTRSTEVA / VTRS
Capitalization15.1B14.2B106%
EBITDA1.56B3.52B44%
Gain YTD-24.955-22.370112%
P/E Ratio22.62238.809%
Revenue15.8B15.4B103%
Total Cash3.23B1.18B272%
Total Debt20.2B18.4B110%
FUNDAMENTALS RATINGS
TEVA vs VTRS: Fundamental Ratings
TEVA
VTRS
OUTLOOK RATING
1..100
5617
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
6155
P/E GROWTH RATING
1..100
131
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (13) in the null industry is somewhat better than the same rating for TEVA (69) in the Pharmaceuticals Generic industry. This means that VTRS’s stock grew somewhat faster than TEVA’s over the last 12 months.

TEVA's Profit vs Risk Rating (67) in the Pharmaceuticals Generic industry is somewhat better than the same rating for VTRS (100) in the null industry. This means that TEVA’s stock grew somewhat faster than VTRS’s over the last 12 months.

TEVA's SMR Rating (94) in the Pharmaceuticals Generic industry is in the same range as VTRS (94) in the null industry. This means that TEVA’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's Price Growth Rating (55) in the null industry is in the same range as TEVA (61) in the Pharmaceuticals Generic industry. This means that VTRS’s stock grew similarly to TEVA’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as TEVA (13) in the Pharmaceuticals Generic industry. This means that VTRS’s stock grew similarly to TEVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TEVAVTRS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
60%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 12 days ago
73%
Bearish Trend 13 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
60%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWFG52.870.26
+0.50%
NYLI Winslow Focused Large Cap Gr ETF
SOR43.830.07
+0.15%
Source Capital
PSQO20.580.01
+0.05%
Palmer Square Credit Opportunities ETF
GGT4.27-0.01
-0.23%
THE Gabelli Multimedia Trust
SIL50.05-0.39
-0.77%
Global X Silver Miners ETF

TEVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
+1.29%
AMRX - TEVA
38%
Loosely correlated
+0.75%
ELAN - TEVA
31%
Poorly correlated
+1.57%
VTRS - TEVA
30%
Poorly correlated
+0.64%
CGC - TEVA
26%
Poorly correlated
+2.70%
BHC - TEVA
26%
Poorly correlated
N/A
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+0.64%
ELAN - VTRS
48%
Loosely correlated
+1.57%
AMRX - VTRS
45%
Loosely correlated
+0.75%
ZTS - VTRS
44%
Loosely correlated
-0.46%
PAHC - VTRS
38%
Loosely correlated
-0.88%
PBH - VTRS
36%
Loosely correlated
+0.79%
More